- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01886768
Double Versus Single Pledget Nasal Anesthesia for Transnasal Endoscopy
Double Versus Single Pledget Method of Nasal Anesthesia for Transnasal Endoscopy: A Randomized Prospective Control Study
Unsedated ultrathin transnasal esophago-gastro-duodenoscopy (UT-EGD), in comparison with conventional peroral EGD (P-EGD) has been shown to be more tolerable, safer, cost-effective and time-efficient. The investigators and in other studies have showed that nasal pledgetting (or commonly termed nasal packing) is better than nasal spray in terms of patient tolerance and visual capacity. Although pledgetting method to a selected meatus can achieve better decongestion effect, epistaxis and nasal pain in some patients are still frustrating to endoscopists.
The investigator has proposed a novel meatus scoring scale to evaluate nasal insertability by anterior rhinoscopy using a transnasal endoscope. The investigator also suggest endoscopic-guided gauze pledgetting can provide precise nasal anesthesia, thereby reducing trauma/bleeding in the nasal cavity and increasing patient tolerance during transnasal endoscopy. Endoscopic guidance to deliver a gauze strip can confirm delivering it to at least the posterior end of a turbinate. We hypothesize that by using endoscopic-guided method, gauze pledgetting to both the inferior nasal meatus (INM) and middle nasal meatus (MNM) simultaneously is more tolerable than only gauze pledgetting to a single meatus.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Hualien county
-
Hualien City, Hualien county, Taiwan, 970
- Recruiting
- Buddhist Tzu Chi Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
All outpatients with epigastric discomfort (non-ulcer dyspepsia), aged 18-65 years are eligibility for this study.
Exclusion Criteria:
- Patients who can not answer questionnaires, who have prior nasal trauma or surgery, recent or present upper gastrointestinal bleeding and coagulopathy are excluded from this study.
- Patients who are allergic to lidocaine and who have uncontrolled hypertension or coronary artery disease are not recruited.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Double pledget nasal anesthesia
All patients in the double pledget nasal anesthesia group receive endoscopic-guided gauze nasal pledgetting to both the inferior nasal meatus and middle nasal meatus.
Each patient will receive an anterior rhinoscopy to select the most patent meatus by a validated meatus scoring scale.
The endoscope is preloaded with a 1.8 mm biopsy forceps to pick up a right-angled gauze strip.
A preloaded biopsy forceps is protruded slowly into the middle meatus first under endoscope monitoring.
The second gauze pledgetting procedure is performed two minutes after the first gauze pledgetting which serves to induce turbinate size reduction to both the INT and MNT.
A gauze strip is at least brought onto the posterior end of the inferior or middle turbinate.
|
By using a transnasal endoscope as a guide and a biopsy forceps, two gauze strips soaked with decongestant and anesthesia will be delivered to the middle meatus followed by the inferior meatus under real-time transnasal endoscopic guidance.
Other Names:
|
ACTIVE_COMPARATOR: Single pledget nasal anesthesia
All patients in the single pledget nasal anesthesia group receive endoscopic-guided gauze nasal pledgetting to either the inferior nasal meatus or middle nasal meatus determined by anterior rhinoscopy.
Each patient will receive an anterior rhinoscopy to select the most patent meatus by a validated meatus scoring scale.
The endoscope is preloaded with a 1.8 mm biopsy forceps to pick up a right-angled gauze strip.
A gauze strip is at least brought onto the posterior end of the inferior or middle turbinate.
|
Another randomized group of patients will also receive endoscopic-guided gauze pledgetting using a transnasal endoscope as a guide and a biopsy forceps.
One gauze strip soaked with decongestant and anesthesia will be delivered to either the middle meatus or inferior meatus determined by anterior rhinoscopy.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The primary outcome measures are tolerability profiles on a validated visual analogue scale
Time Frame: Immediately after transnasal endoscopy up to all questionnaires answered (about 15 minutes)
|
The primary outcome measures are tolerability profiles on a validated visual analogue scale (VAS) and difficulty in inserting the transnasal endoscope through a selected meatus based on a Likert scale.
The Likert scale has 5 points of difficulty: minimal, slight, moderate, substantial, and extreme.
Facing a 5-point VAS card (1 = minimal discomfort to 5 = severe discomfort), all patients give real-time feedback immediately after UT-EGD by speaking or pointing out their scorings for the following: (1) pain during anesthesia, (2) pain during nasal insertions, (3) pain during exsertion, and (4) overall tolerance.
|
Immediately after transnasal endoscopy up to all questionnaires answered (about 15 minutes)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Secondary outcome measures evaluate the side effects of nasal anesthesia
Time Frame: The immediate secondary outcome measures will be evaluated by questionnaires immediately after UT-EGD within 15 minutes and the delayed secondary outcome measures will be evaluated by otolaryngologists within two weeks after UT-EGD.
|
Secondary outcome measures will be evaluated by assisting nurses, who record (a) immediate responses including: (i) epistaxis, (ii) immediately post-procedural side effects including headache, light headiness, and mucous discharge, and (iii) patient's willingness to receive the same procedure the next time, and (b) delayed side effect including (i) persisting nasal discharge, (ii) epistaxis 24 hours after UT- EGD, and (iii) sinusitis all confirmed by otolaryngologists within two weeks after UT-EGD. The visual capacity for the anterior nasal cavity ranking on a 5-point scale (5 represented standard EGD and 1 poor visual quality) is also evaluated by assisting nurses during endoscopic insertion after nasal decongestive anesthesia. |
The immediate secondary outcome measures will be evaluated by questionnaires immediately after UT-EGD within 15 minutes and the delayed secondary outcome measures will be evaluated by otolaryngologists within two weeks after UT-EGD.
|
Collaborators and Investigators
Investigators
- Principal Investigator: Chi-Tan Hu, Budhist Tzu Chi Hospital and Tzu Chi University
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB101-101
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Epistaxis
-
NasaClipEmergency Medical Innovations, LLCRecruiting
-
Bezmialem Vakif UniversityCompleted
-
Izmir Ataturk Training and Research HospitalCompletedTranexamic Acid | Anterior EpistaxisTurkey
-
University of ZurichCompletedNosebleed (Epistaxis) - Posterior or AnteriorSwitzerland
-
University Hospital, Strasbourg, FranceRecruitingEpistaxis, Anterior Ethmoid ArteryFrance
-
Buddhist Tzu Chi General HospitalUnknownInjury Due to Endoscopic Examination | Transnasal Endoscopy Induced Epistaxis | Transnasal Endoscopy Induced Nasal PainTaiwan
-
University of AlbertaCompleted
-
Combined Military Hospital, PakistanCompleted
-
University of British ColumbiaCompleted
Clinical Trials on Double pledget nasal anesthesia (DPNA)
-
Laboratory of Movement, Condorcet, Tournai, BelgiumCompletedOxygen Inhalation TherapyBelgium
-
Johns Hopkins UniversityCompletedHypoxia | Anesthesia Morbidity | EndoscopyUnited States
-
Linmarie SikichEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedAutism Spectrum DisordersUnited States
-
Guangzhou Institute of Respiratory DiseaseUnknownAnaesthesia | Video Assisted Thoracic SurgeryChina
-
Mansoura UniversityCompletedEpidural Anesthesia | Spinal UltrasoundEgypt
-
Ain Shams UniversityUnknownVitamin D Deficiency, Nasal PolyposisEgypt
-
Vanderbilt UniversityCompletedOxygen Administration During Deep SedationUnited States
-
University of OklahomaTerminatedHemodynamics | Central Venous PressureUnited States
-
Ajou University School of MedicineCompletedCholecystitis, Acute | Common Bile Duct CalculiKorea, Republic of
-
Hannover Medical SchoolCompletedEqually of Delivery Systems of Local Anesthesia in BronchoscopyGermany